Which has preferable earnings and valuation, CVRX or CV?

CapsoVision has lower revenue, but higher earnings than CVRx. CapsoVision is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $56.65M 1.28 -$53.31M -$1.98 N/A CapsoVision $13.89M 21.80 -$25.32M -$0.47 N/A

Is CVRX or CV more profitable?

CVRx has a net margin of -84.93% compared to CapsoVision's net margin of -214.74%. CVRx's return on equity of -152.35% beat CapsoVision's return on equity. Company Net Margins Return on Equity Return on Assets CVRx -84.93% -152.35% -50.93% CapsoVision -214.74% -177.85% -135.07%

Does the media refer more to CVRX or CV?

In the previous week, CapsoVision had 3 more articles in the media than CVRx. MarketBeat recorded 11 mentions for CapsoVision and 8 mentions for CVRx. CapsoVision's average media sentiment score of 1.33 beat CVRx's score of 0.01 indicating that CapsoVision is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 0 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral CapsoVision 6 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, RCEL or CVRX?

Avita Medical has higher revenue and earnings than CVRx. Avita Medical is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avita Medical $75.63M 4.46 -$48.59M -$1.44 N/A CVRx $56.65M 1.28 -$53.31M -$1.98 N/A

Is RCEL or CVRX more profitable?

Avita Medical has a net margin of -56.96% compared to CVRx's net margin of -84.93%. Avita Medical's return on equity of 0.00% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets Avita Medical -56.96% N/A -78.53% CVRx -84.93% -152.35% -50.93%

Does the media prefer TMCI or CVRX?

In the previous week, CVRx had 1 more articles in the media than Treace Medical Concepts. MarketBeat recorded 8 mentions for CVRx and 7 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.78 beat CVRx's score of 0.01 indicating that Treace Medical Concepts is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Treace Medical Concepts 4 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CVRx 0 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer CVRX or TLSI?

In the previous week, TriSalus Life Sciences had 3 more articles in the media than CVRx. MarketBeat recorded 11 mentions for TriSalus Life Sciences and 8 mentions for CVRx. TriSalus Life Sciences' average media sentiment score of 0.60 beat CVRx's score of 0.01 indicating that TriSalus Life Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 0 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral TriSalus Life Sciences 3 Very Positive mention(s) 4 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings and valuation, CVRX or ELMD?

Electromed has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CVRx $56.65M 1.28 -$53.31M -$1.98 N/A Electromed $73.78M 3.13 $5.15M $1.31 21.05

Is CVRX or ELMD more profitable?

Electromed has a net margin of 11.34% compared to CVRx's net margin of -84.93%. Electromed's return on equity of 15.71% beat CVRx's return on equity. Company Net Margins Return on Equity Return on Assets CVRx -84.93% -152.35% -50.93% Electromed 11.34% 15.71% 13.37%

CVRx (CVRX) Competitors

$2.72 -0.17 (-5.88%)

Closing price 09/23/2026 04:00 PM Eastern

Extended Trading

$2.73 +0.01 (+0.37%)

As of 04:57 AM Eastern

Compare

CVRX vs. CV, RCEL, TMCI, TLSI, and ELMD

Should you buy CVRx stock or one of its competitors? CVRx's main competitors and comparable companies include CapsoVision (CV), Avita Medical (RCEL), Treace Medical Concepts (TMCI), TriSalus Life Sciences (TLSI), and Electromed (ELMD). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does CVRx compare to CapsoVision?

CVRx (NASDAQ:CVRX) and CapsoVision (NASDAQ:CV) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, media sentiment, profitability, dividends, analyst recommendations and valuation.

In the previous week, CapsoVision had 3 more articles in the media than CVRx. MarketBeat recorded 11 mentions for CapsoVision and 8 mentions for CVRx. CapsoVision's average media sentiment score of 1.33 beat CVRx's score of 0.01 indicating that CapsoVision is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
CapsoVision	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CapsoVision has lower revenue, but higher earnings than CVRx. CapsoVision is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$56.65M	1.28	-$53.31M	-$1.98	N/A
CapsoVision	$13.89M	21.80	-$25.32M	-$0.47	N/A

CVRx currently has a consensus target price of $4.30, suggesting a potential upside of 58.09%. CapsoVision has a consensus target price of $9.50, suggesting a potential upside of 57.02%. Given CVRx's higher probable upside, equities research analysts clearly believe CVRx is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

75.3% of CVRx shares are owned by institutional investors. 16.6% of CVRx shares are owned by insiders. Comparatively, 2.3% of CapsoVision shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

CVRx has a net margin of -84.93% compared to CapsoVision's net margin of -214.74%. CVRx's return on equity of -152.35% beat CapsoVision's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-84.93%	-152.35%	-50.93%
CapsoVision	-214.74%	-177.85%	-135.07%

CVRx has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market. Comparatively, CapsoVision has a beta of -2.47, meaning that its stock price is 347% less volatile than the broader market.

Summary

CVRx beats CapsoVision on 9 of the 15 factors compared between the two stocks.

How does CVRx compare to Avita Medical?

Avita Medical (NASDAQ:RCEL) and CVRx (NASDAQ:CVRX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings, institutional ownership and media sentiment.

Avita Medical has a beta of 2.02, suggesting that its stock price is 102% more volatile than the broader market. Comparatively, CVRx has a beta of 0.76, suggesting that its stock price is 24% less volatile than the broader market.

Avita Medical currently has a consensus price target of $11.40, indicating a potential upside of 4.11%. CVRx has a consensus price target of $4.30, indicating a potential upside of 58.09%. Given CVRx's higher probable upside, analysts clearly believe CVRx is more favorable than Avita Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avita Medical	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.57
CVRx	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

Avita Medical has a net margin of -56.96% compared to CVRx's net margin of -84.93%. Avita Medical's return on equity of 0.00% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avita Medical	-56.96%	N/A	-78.53%
CVRx	-84.93%	-152.35%	-50.93%

27.7% of Avita Medical shares are owned by institutional investors. Comparatively, 75.3% of CVRx shares are owned by institutional investors. 2.2% of Avita Medical shares are owned by insiders. Comparatively, 16.6% of CVRx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, CVRx had 8 more articles in the media than Avita Medical. MarketBeat recorded 8 mentions for CVRx and 0 mentions for Avita Medical. CVRx's average media sentiment score of 0.01 beat Avita Medical's score of 0.00 indicating that CVRx is being referred to more favorably in the news media.

Company	Overall Sentiment
Avita Medical	Neutral
CVRx	Neutral

Avita Medical has higher revenue and earnings than CVRx. Avita Medical is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avita Medical	$75.63M	4.46	-$48.59M	-$1.44	N/A
CVRx	$56.65M	1.28	-$53.31M	-$1.98	N/A

Summary

Avita Medical beats CVRx on 9 of the 16 factors compared between the two stocks.

How does CVRx compare to Treace Medical Concepts?

Treace Medical Concepts (NASDAQ:TMCI) and CVRx (NASDAQ:CVRX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, media sentiment, analyst recommendations, risk, dividends and valuation.

Treace Medical Concepts presently has a consensus target price of $5.17, suggesting a potential upside of 14.63%. CVRx has a consensus target price of $4.30, suggesting a potential upside of 58.09%. Given CVRx's stronger consensus rating and higher probable upside, analysts plainly believe CVRx is more favorable than Treace Medical Concepts.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treace Medical Concepts	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86
CVRx	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

Treace Medical Concepts has a beta of 1.4, meaning that its stock price is 40% more volatile than the broader market. Comparatively, CVRx has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market.

Treace Medical Concepts has a net margin of -28.99% compared to CVRx's net margin of -84.93%. Treace Medical Concepts' return on equity of -71.37% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treace Medical Concepts	-28.99%	-71.37%	-30.49%
CVRx	-84.93%	-152.35%	-50.93%

CVRx has lower revenue, but higher earnings than Treace Medical Concepts. Treace Medical Concepts is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treace Medical Concepts	$212.69M	1.38	-$59M	-$0.93	N/A
CVRx	$56.65M	1.28	-$53.31M	-$1.98	N/A

In the previous week, CVRx had 1 more articles in the media than Treace Medical Concepts. MarketBeat recorded 8 mentions for CVRx and 7 mentions for Treace Medical Concepts. Treace Medical Concepts' average media sentiment score of 0.78 beat CVRx's score of 0.01 indicating that Treace Medical Concepts is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Treace Medical Concepts	4 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

84.1% of Treace Medical Concepts shares are held by institutional investors. Comparatively, 75.3% of CVRx shares are held by institutional investors. 23.4% of Treace Medical Concepts shares are held by company insiders. Comparatively, 16.6% of CVRx shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Treace Medical Concepts beats CVRx on 10 of the 16 factors compared between the two stocks.

How does CVRx compare to TriSalus Life Sciences?

CVRx (NASDAQ:CVRX) and TriSalus Life Sciences (NASDAQ:TLSI) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, media sentiment, analyst recommendations, profitability, earnings, dividends and valuation.

CVRx has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market. Comparatively, TriSalus Life Sciences has a beta of 0.44, indicating that its share price is 56% less volatile than the broader market.

In the previous week, TriSalus Life Sciences had 3 more articles in the media than CVRx. MarketBeat recorded 11 mentions for TriSalus Life Sciences and 8 mentions for CVRx. TriSalus Life Sciences' average media sentiment score of 0.60 beat CVRx's score of 0.01 indicating that TriSalus Life Sciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CVRx	0 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
TriSalus Life Sciences	3 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

CVRx presently has a consensus price target of $4.30, indicating a potential upside of 58.09%. TriSalus Life Sciences has a consensus price target of $10.20, indicating a potential upside of 104.00%. Given TriSalus Life Sciences' stronger consensus rating and higher possible upside, analysts plainly believe TriSalus Life Sciences is more favorable than CVRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
TriSalus Life Sciences	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

75.3% of CVRx shares are owned by institutional investors. Comparatively, 2.6% of TriSalus Life Sciences shares are owned by institutional investors. 16.6% of CVRx shares are owned by insiders. Comparatively, 16.3% of TriSalus Life Sciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

TriSalus Life Sciences has a net margin of -62.59% compared to CVRx's net margin of -84.93%. TriSalus Life Sciences' return on equity of 0.00% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-84.93%	-152.35%	-50.93%
TriSalus Life Sciences	-62.59%	N/A	-64.47%

TriSalus Life Sciences has lower revenue, but higher earnings than CVRx. TriSalus Life Sciences is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$56.65M	1.28	-$53.31M	-$1.98	N/A
TriSalus Life Sciences	$45.15M	6.82	-$39.23M	-$1.30	N/A

Summary

TriSalus Life Sciences beats CVRx on 10 of the 16 factors compared between the two stocks.

How does CVRx compare to Electromed?

CVRx (NASDAQ:CVRX) and Electromed (NYSE:ELMD) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, profitability, analyst recommendations, earnings and media sentiment.

CVRx currently has a consensus target price of $4.30, suggesting a potential upside of 58.09%. Electromed has a consensus target price of $43.75, suggesting a potential upside of 58.69%. Given Electromed's stronger consensus rating and higher possible upside, analysts clearly believe Electromed is more favorable than CVRx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CVRx	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17
Electromed	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

CVRx has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market. Comparatively, Electromed has a beta of 0.46, indicating that its share price is 54% less volatile than the broader market.

In the previous week, CVRx had 8 more articles in the media than Electromed. MarketBeat recorded 8 mentions for CVRx and 0 mentions for Electromed. CVRx's average media sentiment score of 0.01 beat Electromed's score of 0.00 indicating that CVRx is being referred to more favorably in the media.

Company	Overall Sentiment
CVRx	Neutral
Electromed	Neutral

Electromed has higher revenue and earnings than CVRx. CVRx is trading at a lower price-to-earnings ratio than Electromed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CVRx	$56.65M	1.28	-$53.31M	-$1.98	N/A
Electromed	$73.78M	3.13	$5.15M	$1.31	21.05

75.3% of CVRx shares are owned by institutional investors. Comparatively, 40.8% of Electromed shares are owned by institutional investors. 16.6% of CVRx shares are owned by company insiders. Comparatively, 10.5% of Electromed shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Electromed has a net margin of 11.34% compared to CVRx's net margin of -84.93%. Electromed's return on equity of 15.71% beat CVRx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CVRx	-84.93%	-152.35%	-50.93%
Electromed	11.34%	15.71%	13.37%

Summary

Electromed beats CVRx on 11 of the 16 factors compared between the two stocks.

Get CVRx News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CVRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CVRX vs. The Competition

Export

Metric	CVRx	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$76.99M	$5.58B	$7.31B	$13.29B
Dividend Yield	N/A	1.79%	2.52%	12.57%
P/E Ratio	-1.37	25.26	274.07	25.69
Price / Sales	1.28	71.57	643.13	79.17
Price / Cash	N/A	33.02	77.80	52.76
Price / Book	1.81	5.78	10.47	6.32
Net Income	-$53.31M	$151.55M	$3.49B	$359.73M
7 Day Performance	-9.33%	0.01%	-0.67%	0.17%
1 Month Performance	-13.65%	-3.51%	-3.17%	-3.27%
1 Year Performance	-63.54%	6.37%	15.13%	5.58%

CVRx Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
CVRX CVRx	4.1155 of 5 stars	$2.72 -5.9%	$4.30 +58.1%	-63.5%	$76.99M	$56.65M	N/A	223	Analyst Forecast
CV CapsoVision	3.4758 of 5 stars	$6.38 -2.0%	$9.50 +48.9%	+32.4%	$319.32M	$13.55M	N/A	99	News Coverage Positive News Insider Trade
RCEL Avita Medical	0.927 of 5 stars	$10.21 +0.2%	$11.40 +11.7%	+100.9%	$314.26M	$71.61M	N/A	226	Analyst Forecast
TMCI Treace Medical Concepts	2.9018 of 5 stars	$4.58 -1.1%	$5.17 +12.9%	-33.7%	$297.86M	$205.31M	N/A	450
TLSI TriSalus Life Sciences	2.3387 of 5 stars	$4.78 +0.2%	$8.67 +81.3%	+2.7%	$294.33M	$45.08M	N/A	102	Trending News Analyst Forecast Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CVRX) was last updated on 9/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CVRx (CVRX) Competitors